Nerve-block therapy
August 5, 2016
BLOCKING neural signals may
become a whole new way to
manage certain diseases such
as type 2 diabetes, arthritis
and asthma, according to
GlaxoSmithKline vice-president of
bioelectronics Kris Famm.
Animal experiments have
attached tiny silicone cuffs,
containing electrodes, around
a nerve and then used a power
supply to control the nerve’s
messages, restoring sensitivity to
insulin in T2 diabetes rat models.
“It isn’t just a one-trick-pony, it
is something that if we get it right
could have a new class of therapies
on our hands,” Famm told the BBC.
He added that the fledgling
field of bioelectronics was only
“scratching the surface” when
it came to understanding the
geography of nerve signalling.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 16